By Gina Shaw
When inspectors from the FDA find conditions at a 503B compounding facility that they believe could constitute violations of the Food Drug and Cosmetic (FD&C) Act and related acts, they issue a Form FDA 483—a list of objectionable conditions and practices observed during the inspection.
MAY 23, 2024